Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for DIOFF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 35.38%
March 31, 2026 37.41%
December 31, 2025 50.22%
September 30, 2025 45.50%
June 30, 2025 1.20%
March 31, 2025 24.51%
December 31, 2024 51.58%
September 30, 2024 -1.77%
June 30, 2024 18.58%
March 31, 2024 40.53%
December 31, 2023 -106.3%
September 30, 2023 14.17%
June 30, 2023 13.39%
March 31, 2023 -53.97%
December 31, 2022 -19.89%
September 30, 2022 -21.47%
June 30, 2022 65.56%
March 31, 2022
December 31, 2021
September 30, 2021 83.75%
June 30, 2021 86.31%
March 31, 2021
December 31, 2020 92.80%
September 30, 2020 47.91%
June 30, 2020 12.67%
Date Value
March 31, 2020 39.54%
December 31, 2019 55.13%
September 30, 2019 64.30%
June 30, 2019 56.68%
March 31, 2019 50.33%
December 31, 2018
September 30, 2018 64.88%
June 30, 2018 80.27%
March 31, 2018 50.89%
December 31, 2017 57.79%
September 30, 2017 44.04%
June 30, 2017 58.62%
March 31, 2017 80.49%
December 31, 2016 78.93%
September 30, 2016 68.36%
June 30, 2016 58.08%
March 31, 2016 41.49%
December 31, 2015 67.37%
September 30, 2015 -5.56%
June 30, 2015 69.09%
March 31, 2015 22.87%
December 31, 2014 38.30%
September 30, 2014 28.40%
June 30, 2014 12.39%
March 31, 2014 13.41%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Castellum AB 26.20%
Pandox AB 10.02%
Fabege AB 34.49%
Gyrodyne LLC --
IRSA Inversiones y Representaciones SA -22.56%